Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Thyroxine (T4) may help heal skin wounds by promoting new skin and blood vessel growth.

Menopause-related skin changes may increase fungal infections and inflammation.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Gray hair can potentially be reversed, leading to new treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.